Abstract
Hypokalemic myopathy may occur in several infections. We report a case of severe and transient myopathy secondary to hypokalemia induced by chronic intenstinal infection withGiardia lamblia in a patient with common variable hypogammaglobulinemia. Hypokalemic myopathy is documented by serum enzymes, electromyography (reduction in the number of voluntarily activated motor unit action potentials and an increase in polyphasic motor unit action potentials, and pathological changes (hematoxylin-eosin, ATPase staining). The case reported involves hypokalemic myopathy induced by giardiasis in a patient with primary immunodeficiency; the histopathological changes observed in a skin/muscle biopsy from this patient are described for the first time.
Similar content being viewed by others
References
Dickson BA, Franks RC. Aldosterone-producing adenoma presenting with hypokllemic myopathy. Case report and review. Clin Pediatr (Phila) 1988; 27: 344.
Ishikawa S, Saito T, Okada K, Atsumi T, Kuzuya T. Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizin-induced pseudoaldosteronims. Endocrinol Jpn 1985; 32: 793.
Shintani S, Murase H, Tsukagoshi H, Shiigai T. Glycyrrhizin (licorice)-induced hypokalemic myopathy. Report of 2 cases and review of the literature. Eur Neurol 1992; 32: 44.
Hayashi K, Hayashi R, Maruyama K, Yanagisawa N. Histopathologic and MRI findings in hypokalemic myopathy induced by glycyrrhizin. Acta Neurol Scand 1995; 92: 127.
Cosentino F, Mantelli I, Cosentino F. Hypokalemic myopathy, high levels of muscle enzymes and myocardial ischemia secondary to the topical administration of 9-alpha-fluoro-prednisolone. Clin Ter 1986; 116: 509.
Molins A, Alvarez-Sabin J, Montalban J, Molero J, Alegre J, Codina A. Hypopotassemic myopathy caused by topical administration of 9-alpha-fluoroprednisolone. Neurologiga 1987; 2: 244.
Shintani S, Shiigai T, Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur Neurol 1991; 31: 396.
Rizzi R, Micoli A, Giaculli G, Lella A, Mariella F. Hypokalemic myopathy during prolonged anti-hypertensive therapy with indapamide. Clin Ter 1985; 114: 233.
Williams SG, Davison AG, Glynn MJ. Hypokalaemic rhabdomyolysis: an unusual presentation of coeliac disease. Eur J Gastroenterol Hepatol 1995; 7: 183.
Murai K, Tsuruta K, Yamamura Y, Kuribayashi T, Kurihara T, Matsukura S. Hypokalemic myopathy associated with radiation enteropathy. Eur Neurol 1986; 25: 444.
Orman RA, Lewis JB Jr. Flaccid quadriparesis associated withYersinia enterocolitis-induced hypokalemia. Arch Intern Med 1989; 149: 1193.
Hill DR:Giardia lamblia. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases, 3rd edn. New York: Churchill Livingstone: 1990: 2110–2115.
Cervello A, Alfaro A, Chumillas MJ. Hypokalemic myopathy induced byGiardia lamblia. N Engl J Med 1993; 329: 210.
Dubowitz V. Muscle biopsy. A practical approach. 2nd edn. London: Bailliere Tindall, 1985.
Engel AG. Periodic paralysis. In: Engel AG, Banker BQ, eds. Myology, basic and clinical. New York: McGraw-Hill; 1986: 1843–1870.
Engel AG. Hypokalemic and hyperkalemic periodic paralyses. In: Goldenson E, Apel S, eds. Scientific approaches to clinical neurology. vol 2. Philadelphia: Lea and Febiger. 1977: 1742–1765.
McArdle B. Metabolic myopathies. Am J Med 1963; 35: 661.
Klein R, Egan T, Usher P. Changes in sodium, potassium and water in hyperkalemic familial periodic paralysis. Metabolism 1960; 9: 1005.
Samaha FJ. Hyperkalemic periodic paralysis. Arch Neurol 1965; 12: 145.
Resnick JS, Engel WK, Grigss RC, Stam AC. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 1968; 278: 582.
Atsumi T, Ishikawa S, Miyatake T, Yoshida M. Myopathy and primary aldosteronism: electron microscopic study. Neurology 1979; 29: 1348.
Bautista J, Gil-Neciga E, Gil-Peralta A. Hypokalemic periodic paralysis in primary hyperaldosteronism: subclinical myopathy with atrophy of the type 2A muscle fibers. Eur Neurol 1979; 18: 415.
Addiss DG, Lengerich EJ. Hypokalemic myopathy induced byGiardia lamblia. N Engl J Med 1994; 330: 66.
Warhurst DC, Smith H. Getting to the guts of the problem. Parasitol Today 1992; 8: 292.
Health Care Financing Administration Medicare provider analysis and review file (machine-readable data files). Baltimore: Department of Health and Human Services, 1984–1990.
Mineral and electrolyte disorders. In: Layzer RB, ed. Neuromuscular manifestations by systemic disease. Contemporay neurology series. vol 25. Philadelphia. Davis: 1985: 47-77.
Harvey AM, Johns RJ, McKusick VA, Owens AH Jr, Ross RS. eds. The principles and practice of medicine, 22nd edn. Norwalk, Connecticut: Appleton and Lange; 1988: 701.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geovese, A., Spadaro, G., Santoro, L. et al. Giardiasis as a cause of hypokalemic myopathy in congenital immunodeficiency. Int J Clin Lab Res 26, 132–135 (1996). https://doi.org/10.1007/BF02592356
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02592356